We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stem Cell Breakthrough May Provide New Options for Treatment of Motor Neuron Disease

By LabMedica International staff writers
Posted on 03 Apr 2012
Print article
An international group of researchers has created motor neurons using skin cells from a patient with an inherited form of motor neuron disease (MND). The scientists demonstrated that abnormalities of a protein called TDP-43, implicated in more than 90% of cases of MND, resulted in the death of motor neuron cells. This is the first time that scientists have been able to validate the direct effect of abnormal TDP-43 on human motor neurons.

The study, led by the University of Edinburgh’s (UK) Euan MacDonald Centre for Motor Neuron Disease Research, was performed in collaboration with King’s College London (UK), Columbia University (New York, NY, USA), and the University of San Francisco (CA, USA).

MND is a debilitating, untreatable, and ultimately lethal disorder that results from progressive loss of the motor nerves--motor neurons--that control speech movement, and breathing. Prof. Siddharthan Chandran, of the University of Edinburgh, said, “Using patient stem cells to model MND in a dish offers untold possibilities for how we study the cause of this terrible disease as well as accelerating drug discovery by providing a cost-effective way to test many thousands of potential treatments.”

The study, funded by the MND Association (Northampton, UK), was published ahead of print March 26, 2012, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). Dr. Brian Dickie, director of research and development for the MND Association, said, “This advance is a significant milestone on the road to developing a laboratory model of MND that faithfully reflects the cellular events happening in the patient. “It is also a testament to the importance of international collaboration, with eminent scientists from leading institutions around the world focused on the common goal of understanding, and ultimately, defeating this devastating disease.”

Related Links:

University of Edinburgh
King’s College London
Columbia University






Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Food Allergens Assay Kit
Allerquant 14G A
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.